Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dapeng Li

Showing results (781-790 of 791) with videos related to

Pageof 80
Sort By:
Biorxiv : the Preprint Server for Biology|February 4, 2022
Breadth of SARS-CoV-2 Neutralization and Protection Induced by a Nanoparticle VaccineDapeng Li, David R Martinez, Alexandra Schäfer, et al.
Biorxiv : the Preprint Server for Biology|January 8, 2024
Broadly neutralizing antibody induction by non-stabilized SARS-CoV-2 Spike mRNA vaccination in nonhuman primatesR Dilshan Malewana, Victoria Stalls, Aaron May, et al.
Science Translational Medicine|June 11, 2025
Nonstabilized SARS-CoV-2 spike mRNA vaccination induces broadly neutralizing antibodies in nonhuman primatesR Dilshan Malewana, Victoria Stalls, Aaron May, et al.
Nature Communications|October 23, 2022
Breadth of SARS-CoV-2 neutralization and protection induced by a nanoparticle vaccineDapeng Li, David R Martinez, Alexandra Schäfer, et al.
Nature|May 10, 2021
Neutralizing antibody vaccine for pandemic and pre-emergent coronavirusesKevin O Saunders, Esther Lee, Robert Parks, et al.
Lancet (London, England)|October 19, 2024
Cadonilimab plus platinum-based chemotherapy with or without bevacizumab as first-line treatment for persistent, recurrent, or metastatic cervical cancer (COMPASSION-16): a randomised, double-blind, placebo-controlled phase 3 trial in ChinaXiaohua Wu, Yang Sun, Hongying Yang, et al.
Nature Communications|March 14, 2026
Cadonilimab plus chemotherapy with or without bevacizumab as first-line treatment for advanced cervical cancer: subgroup analyses from the COMPASSION-16 phase 3 trialYang Sun, Hongying Yang, Jing Wang, et al.
Biorxiv : the Preprint Server for Biology|March 10, 2021
Vaccination with SARS-CoV-2 Spike Protein and AS03 Adjuvant Induces Rapid Anamnestic Antibodies in the Lung and Protects Against Virus Challenge in Nonhuman PrimatesJoseph R Francica, Barbara J Flynn, Kathryn E Foulds, et al.
Biorxiv : the Preprint Server for Biology|January 14, 2021
The functions of SARS-CoV-2 neutralizing and infection-enhancing antibodies in vitro and in mice and nonhuman primatesDapeng Li, Robert J Edwards, Kartik Manne, et al.
Cell|July 9, 2021
In vitro and in vivo functions of SARS-CoV-2 infection-enhancing and neutralizing antibodiesDapeng Li, Robert J Edwards, Kartik Manne, et al.
Pageof 80

Showing results (781-790 of 791) with videos related to

Sort By:
Pageof 80
Biorxiv : the Preprint Server for Biology|February 4, 2022
Breadth of SARS-CoV-2 Neutralization and Protection Induced by a Nanoparticle VaccineDapeng Li, David R Martinez, Alexandra Schäfer, et al.
Biorxiv : the Preprint Server for Biology|January 8, 2024
Broadly neutralizing antibody induction by non-stabilized SARS-CoV-2 Spike mRNA vaccination in nonhuman primatesR Dilshan Malewana, Victoria Stalls, Aaron May, et al.
Science Translational Medicine|June 11, 2025
Nonstabilized SARS-CoV-2 spike mRNA vaccination induces broadly neutralizing antibodies in nonhuman primatesR Dilshan Malewana, Victoria Stalls, Aaron May, et al.
Nature Communications|October 23, 2022
Breadth of SARS-CoV-2 neutralization and protection induced by a nanoparticle vaccineDapeng Li, David R Martinez, Alexandra Schäfer, et al.
Nature|May 10, 2021
Neutralizing antibody vaccine for pandemic and pre-emergent coronavirusesKevin O Saunders, Esther Lee, Robert Parks, et al.
Lancet (London, England)|October 19, 2024
Cadonilimab plus platinum-based chemotherapy with or without bevacizumab as first-line treatment for persistent, recurrent, or metastatic cervical cancer (COMPASSION-16): a randomised, double-blind, placebo-controlled phase 3 trial in ChinaXiaohua Wu, Yang Sun, Hongying Yang, et al.
Nature Communications|March 14, 2026
Cadonilimab plus chemotherapy with or without bevacizumab as first-line treatment for advanced cervical cancer: subgroup analyses from the COMPASSION-16 phase 3 trialYang Sun, Hongying Yang, Jing Wang, et al.
Biorxiv : the Preprint Server for Biology|March 10, 2021
Vaccination with SARS-CoV-2 Spike Protein and AS03 Adjuvant Induces Rapid Anamnestic Antibodies in the Lung and Protects Against Virus Challenge in Nonhuman PrimatesJoseph R Francica, Barbara J Flynn, Kathryn E Foulds, et al.
Biorxiv : the Preprint Server for Biology|January 14, 2021
The functions of SARS-CoV-2 neutralizing and infection-enhancing antibodies in vitro and in mice and nonhuman primatesDapeng Li, Robert J Edwards, Kartik Manne, et al.
Cell|July 9, 2021
In vitro and in vivo functions of SARS-CoV-2 infection-enhancing and neutralizing antibodiesDapeng Li, Robert J Edwards, Kartik Manne, et al.
Pageof 80